These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 431486)

  • 21. How do things stand with cisplatin?
    Check W
    JAMA; 1978 Dec; 240(23):2521-2525. PubMed ID: 712945
    [No Abstract]   [Full Text] [Related]  

  • 22. [Prospects for using platinum coordination compounds possessing antitumor activity].
    Sidorik EP; Burlaka AP; Sirdorik OA; Korchevaia LM
    Eksp Onkol; 1984; 6(6):6-12. PubMed ID: 6396067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cisplatin dose intensity.
    Ozols RF
    Semin Oncol; 1989 Aug; 16(4 Suppl 6):22-30. PubMed ID: 2669135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prophylactic efficacy of timiperone (Tolopelon) in vomiting caused by DDP].
    Tari K; Satake I; Takahashi M; Matsuzawa M; Akazawa S
    Gan To Kagaku Ryoho; 1985 Jan; 12(1):166-8. PubMed ID: 4038448
    [No Abstract]   [Full Text] [Related]  

  • 25. Lhermitte's sign as a complication of cisplatin-containing chemotherapy for testicular cancer.
    Eeles R; Tait DM; Peckham MJ
    Cancer Treat Rep; 1986 Jul; 70(7):905-7. PubMed ID: 2424594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. History and development of cisplatin in the management of malignant disease.
    Eustace P
    Cancer Nurs; 1980 Oct; 3(5):373-8. PubMed ID: 6902674
    [No Abstract]   [Full Text] [Related]  

  • 27. Cisplatin or carboplatin for ovarian and testicular cancer?
    Drug Ther Bull; 1994 Aug; 32(8):62-3. PubMed ID: 7635038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitation of cis-diamminedichloroplatinum II (cisplatin)-DNA-intrastrand adducts in testicular and ovarian cancer patients receiving cisplatin chemotherapy.
    Reed E; Yuspa SH; Zwelling LA; Ozols RF; Poirier MC
    J Clin Invest; 1986 Feb; 77(2):545-50. PubMed ID: 3944268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cis-platinum: a new anticancer agent.
    Williams CJ; Whitehouse JM
    Br Med J; 1979 Jun; 1(6179):1689-91. PubMed ID: 380759
    [No Abstract]   [Full Text] [Related]  

  • 30. [The role of glutathione and glutathione-S-transferase in neoplasm drug resistance].
    Gorozhanskaia EG; Koroleva EIu; Egorova NI; Larionova VB; Garin AM; Kushlinskiĭ NE
    Biull Eksp Biol Med; 1998 May; 125(5):562-5. PubMed ID: 9644560
    [No Abstract]   [Full Text] [Related]  

  • 31. [Chemotherapy of testicular tumors].
    Cortes Funes H; Leiva Galvis O
    Actas Urol Esp; 1981; 5(5):259-72. PubMed ID: 6174033
    [No Abstract]   [Full Text] [Related]  

  • 32. DNA adducts induced by platinum drug chemotherapeutic agents in human tissues.
    Poirier MC; Shamkhani H; Reed E; Tarone RE; Gupta-Burt S
    Prog Clin Biol Res; 1992; 374():197-212. PubMed ID: 1620704
    [No Abstract]   [Full Text] [Related]  

  • 33. [Prospects of antiblastic chemotherapy in the treatment of autochthonous trophoblastic tumors. (Description of 2 clinical cases)].
    Pastina R; Varagnolo C
    Attual Ostet Ginecol; 1967; 12(4):337-53. PubMed ID: 4298896
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of genitourinary tumours with cis-dichlorodiammineplatinum(II): experience in 250 patients.
    Merrin CE
    Cancer Treat Rep; 1979; 63(9-10):1579-84. PubMed ID: 574057
    [No Abstract]   [Full Text] [Related]  

  • 35. [Cis-platinum (DDP) in the treatment of advanced malignant ovarian tumors--report of 30 cases].
    Liu LY
    Zhonghua Zhong Liu Za Zhi; 1983 Nov; 5(6):433-6. PubMed ID: 6687118
    [No Abstract]   [Full Text] [Related]  

  • 36. Curing metastatic cancer: lessons from testicular germ-cell tumours.
    Masters JR; Köberle B
    Nat Rev Cancer; 2003 Jul; 3(7):517-25. PubMed ID: 12835671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progress in the management of testicular germ-cell tumours.
    Oliver RT
    Practitioner; 1982 Nov; 226(1373):1903-15. PubMed ID: 6891458
    [No Abstract]   [Full Text] [Related]  

  • 38. [Toxicity and efficacy of chemotherapy dependent on circadian time of cytostatic drug administration].
    Zuchowska-Vogelgesang B; Pernal J; Zemełka T
    Przegl Lek; 1996; 53(12):870-3. PubMed ID: 9163011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase II study of AMSA in refractory testicular cancer.
    Williams SD; Duncan P; Einhorn LH
    Cancer Treat Rep; 1983 Mar; 67(3):309-10. PubMed ID: 6687560
    [No Abstract]   [Full Text] [Related]  

  • 40. Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 and Children's Cancer Group 8882.
    Cushing B; Giller R; Cullen JW; Marina NM; Lauer SJ; Olson TA; Rogers PC; Colombani P; Rescorla F; Billmire DF; Vinocur CD; Hawkins EP; Davis MM; Perlman EJ; London WB; Castleberry RP; ;
    J Clin Oncol; 2004 Jul; 22(13):2691-700. PubMed ID: 15226336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.